Actively Recruiting
The Gynecological Cancer Associated Thrombosis (GynCAT) Study
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2024-09-19
1800
Participants Needed
1
Research Sites
128 weeks
Total Duration
On this page
Sponsors
F
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead Sponsor
F
Fondazione Umberto Veronesi
Collaborating Sponsor
AI-Summary
What this Trial Is About
GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.
CONDITIONS
Official Title
The Gynecological Cancer Associated Thrombosis (GynCAT) Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female sex
- Diagnosis of gynecologic neoplasm (ovarian, tubal, uterine, cervical, vaginal, vulvar neoplasm)
- Planned new line of systemic antineoplastic treatment
- Age of 18 years or older
- Accordance of Informed Consent
You will not qualify if you...
- Pregnant or breastfeeding women
- Indication to receive therapeutic dose anticoagulant therapy (e.g., atrial fibrillation, mechanical heart valve)
- Diagnosis of symptomatic venous thromboembolism at the time of screening for enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Agostino Gemelli University Polyclinic Foundation IRCCS
Rome, Italy, 00168
Actively Recruiting
Research Team
R
Roberto Pola, PhD; MD
CONTACT
P
Paolo Santini, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here